Add to ORKGIn older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly medicare patients treated with rosiglitazone or pioglitazone. JAMA
Objective To determine the comparative effects of the thiazolidinediones (rosiglitazone and pioglita...
Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial inf...
Diabetes mellitus is associated with a number of serious microvascular and macrovascularcomplication...
OBJECTIVE: To compare the risk of acute myocardial infarction, heart failure, and death in patients ...
Background:Recentmeta-analyses have raised the pos-sibility that rosiglitazone maleate may increase ...
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events a...
Background The difference of cardiovascular effects between rosiglitazone and pioglitazone treatment...
Background: Recent studies have raised concerns about risk of heart failure (HF) in type 2 diabetic...
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events a...
cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes Loke YK, Kwok CS...
Background: Thiazolidinediones (TZDs) - rosiglitazone and pioglitazone - a class of insulin sensitiz...
BackgroundStudies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (CVD...
Background Studies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (C...
BACKGROUND: A recent meta-analysis raised concern regarding an increased risk of myocardial infarcti...
[[abstract]]Background and objective: Concern has been expressed over the cardiovascular risks assoc...
Objective To determine the comparative effects of the thiazolidinediones (rosiglitazone and pioglita...
Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial inf...
Diabetes mellitus is associated with a number of serious microvascular and macrovascularcomplication...
OBJECTIVE: To compare the risk of acute myocardial infarction, heart failure, and death in patients ...
Background:Recentmeta-analyses have raised the pos-sibility that rosiglitazone maleate may increase ...
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events a...
Background The difference of cardiovascular effects between rosiglitazone and pioglitazone treatment...
Background: Recent studies have raised concerns about risk of heart failure (HF) in type 2 diabetic...
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events a...
cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes Loke YK, Kwok CS...
Background: Thiazolidinediones (TZDs) - rosiglitazone and pioglitazone - a class of insulin sensitiz...
BackgroundStudies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (CVD...
Background Studies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (C...
BACKGROUND: A recent meta-analysis raised concern regarding an increased risk of myocardial infarcti...
[[abstract]]Background and objective: Concern has been expressed over the cardiovascular risks assoc...
Objective To determine the comparative effects of the thiazolidinediones (rosiglitazone and pioglita...
Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial inf...
Diabetes mellitus is associated with a number of serious microvascular and macrovascularcomplication...